Unique ID issued by UMIN | UMIN000040147 |
---|---|
Receipt number | R000045765 |
Scientific Title | Subepithelial injection of onabotulinumtoxin A for overactive bladder |
Date of disclosure of the study information | 2020/05/01 |
Last modified on | 2023/10/16 11:12:07 |
Subepithelial injection of onabotulinumtoxin A for overactive bladder
Onabotulinumtoxin A injection in overactive bladder
Subepithelial injection of onabotulinumtoxin A for overactive bladder
Onabotulinumtoxin A injection in overactive bladder
Japan |
Refractory overactive bladder
Urology |
Others
NO
To evaluate effect and safety of subepithelial injection of Botulinum toxin A for patients with refractory overactive bladder.
Safety,Efficacy
Change of the number of daily urinary incontinence at week 12 after treatment
Change of the number of urinary urgency incontinence, micturition, nocturia and evaluation of adverse event.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
After solving Botulinum toxin A 100 units by normal saline 10 mL, 20 sites in the detrusor muscle using injection needle, avoiding the trigone of the bladder.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients has non-neurogenic overactive bladder.
2)written informed consent is required.
3)At least twice a week of urinary urge incontinence was seen after anticholinergics and/or beta3-adrenergic receptor agonists could not be continued because of adverse effects.
1) The patient has apparent neurogenic diseases causing urinary tract symptoms.
2) The patient underwent treatment with botulinum toxin A.
3) The patient underwent the surgery of lower urinary tract within 1 year.
4) Postvoid residual urine is 100mL or greater.
5) The patient has apparent lower urinary tract obstruction and/or weak detrusor.
6) The patient has predominantly stress urinary incontinence.
7) The patient has active urinary tract infection, malignance and/or bladder stone.
8) The patient is pregnant or breast-feed, or have possibility of such matter within 1 year.
9) The patient is diagnosed as having myasthenia gravis, Lambert-Eaton syndromeconduct , amyotrophic lateral sclerosis.
10)The patient has disturbance of swallowing and/or respiration.
11)The patient has mental and/or cognitive disturbance to conduct the clinical trial.
12) The patient is judged as being unsuitable for the trial by the researcher.
40
1st name | Hirotaka |
Middle name | |
Last name | Sato |
Hokusuikai Kinen Hospital
department of urology
3100035
3-2-1, Higashihara-cyo, Mito-city, Ibaraki-ken
0293033003
hirotakasato911@yahoo.co.jp
1st name | Hirotaka |
Middle name | |
Last name | Sato |
Hokusuikai Kinen Hospital
department of urology
3100035
3-2-1, Higashihara-cyo, Mito-city, Ibaraki-ken
0293033003
hirotakasato911@yahoo.co.jp
Hokusuikai kinen Hospital
Department of Urology
Department Urology, Hokusuikai kinen Hospital
Self funding
Japan
Hokusuikai Kinen Hospital
3-2-1, Higashihara-cyo, Mito-city, Ibaraki-ken
0293033003
hirotakasato911@yahoo.co.jp
NO
2020 | Year | 05 | Month | 01 | Day |
Unpublished
Open public recruiting
2020 | Year | 01 | Month | 15 | Day |
2020 | Year | 03 | Month | 26 | Day |
2020 | Year | 05 | Month | 01 | Day |
2027 | Year | 06 | Month | 30 | Day |
2027 | Year | 07 | Month | 31 | Day |
2027 | Year | 07 | Month | 31 | Day |
2027 | Year | 08 | Month | 31 | Day |
2020 | Year | 04 | Month | 13 | Day |
2023 | Year | 10 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045765
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |